Singh K, Fronza R, Evens H, Chuah M, VandenDriessche T
Mol Ther Methods Clin Dev. 2024; 32(4):101365.
PMID: 39655309
PMC: 11626537.
DOI: 10.1016/j.omtm.2024.101365.
Kasimsetty A, Hwang Y, Everett J, McFarland A, Zolnoski S, Lu T
Mol Ther Methods Clin Dev. 2024; 32(4):101364.
PMID: 39618424
PMC: 11607603.
DOI: 10.1016/j.omtm.2024.101364.
Zhu M, Fang Y, Sun Y, Li S, Yu J, Xiong B
Adv Sci (Weinh). 2024; 11(48):e2407373.
PMID: 39488795
PMC: 11672274.
DOI: 10.1002/advs.202407373.
Puzzo F, Crossley M, Goswami A, Zhang F, Pekrun K, Garzon J
Mol Ther. 2024; 32(12):4256-4271.
PMID: 39369271
PMC: 11638834.
DOI: 10.1016/j.ymthe.2024.09.035.
Bazick H, Mao H, Niehaus J, Wolter J, Zylka M
Mol Ther. 2024; 32(11):4122-4137.
PMID: 39367606
PMC: 11573598.
DOI: 10.1016/j.ymthe.2024.09.032.
Strategies to improve safety profile of AAV vectors.
Suoranta T, Laham-Karam N, Yla-Herttuala S
Front Mol Med. 2024; 2:1054069.
PMID: 39086961
PMC: 11285686.
DOI: 10.3389/fmmed.2022.1054069.
Targeted knock-in of cDNA into the locus leads to myeloid phenotypic correction of p47 -deficient chronic granulomatous disease.
Siow K, Gungor M, Wrona D, Raimondi F, Pastukhov O, Tsapogas P
Mol Ther Nucleic Acids. 2024; 35(3):102229.
PMID: 38952440
PMC: 11215332.
DOI: 10.1016/j.omtn.2024.102229.
Strategies for enhanced gene delivery to the central nervous system.
Gao Z
Nanoscale Adv. 2024; 6(12):3009-3028.
PMID: 38868835
PMC: 11166101.
DOI: 10.1039/d3na01125a.
AAV-mediated genome editing is influenced by the formation of R-loops.
Puzzo F, Crossley M, Goswami A, Zhang F, Pekrun K, Garzon J
bioRxiv. 2024; .
PMID: 38766176
PMC: 11100726.
DOI: 10.1101/2024.05.07.592855.
In vivo genome editing via CRISPR/Cas9-mediated homology-independent targeted integration for Bietti crystalline corneoretinal dystrophy treatment.
Meng X, Jia R, Zhao X, Zhang F, Chen S, Yu S
Nat Commun. 2024; 15(1):3773.
PMID: 38710738
PMC: 11074121.
DOI: 10.1038/s41467-024-48092-9.
Hemophilia B and gene therapy: a new chapter with etranacogene dezaparvovec.
Anguela X, High K
Blood Adv. 2024; 8(7):1796-1803.
PMID: 38592711
PMC: 11006816.
DOI: 10.1182/bloodadvances.2023010511.
Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a Highlight.
Zhang Z, Zhang S, Wong H, Li D, Feng B
BioDrugs. 2024; 38(3):369-385.
PMID: 38489061
PMC: 11055778.
DOI: 10.1007/s40259-024-00654-5.
Targeted nonviral delivery of genome editors in vivo.
Tsuchida C, Wasko K, Hamilton J, Doudna J
Proc Natl Acad Sci U S A. 2024; 121(11):e2307796121.
PMID: 38437567
PMC: 10945750.
DOI: 10.1073/pnas.2307796121.
Glycogen storage disease type I: Genetic etiology, clinical manifestations, and conventional and gene therapies.
Zhong J, Gou Y, Zhao P, Dong X, Guo M, Li A
Pediatr Discov. 2024; 1(2).
PMID: 38370424
PMC: 10874634.
DOI: 10.1002/pdi3.3.
Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells.
Gomez-Moreno A, San Sebastian E, Moya J, Gomollon-Zueco P, Isola S, Vales A
Pharmaceutics. 2023; 15(10).
PMID: 37896219
PMC: 10610421.
DOI: 10.3390/pharmaceutics15102459.
CRISPR-Cas9 engineering of the RAG2 locus via complete coding sequence replacement for therapeutic applications.
Allen D, Knop O, Itkowitz B, Kalter N, Rosenberg M, Iancu O
Nat Commun. 2023; 14(1):6771.
PMID: 37891182
PMC: 10611791.
DOI: 10.1038/s41467-023-42036-5.
Targeted Delivery of Chimeric Antigen Receptor into T Cells via CRISPR-Mediated Homology-Directed Repair with a Dual-AAV6 Transduction System.
Moco P, Farnos O, Sharon D, Kamen A
Curr Issues Mol Biol. 2023; 45(10):7705-7720.
PMID: 37886930
PMC: 10605174.
DOI: 10.3390/cimb45100486.
Epithelioid neoplasm of the spinal cord in a child with spinal muscular atrophy treated with onasemnogene abeparvovec.
Retson L, Tiwari N, Vaughn J, Bernes S, Adelson P, Mansfield K
Mol Ther. 2023; 31(10):2991-2998.
PMID: 37598295
PMC: 10556221.
DOI: 10.1016/j.ymthe.2023.08.013.
Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathy.
Kabra M, Shahi P, Wang Y, Sinha D, Spillane A, Newby G
J Clin Invest. 2023; 133(19).
PMID: 37561581
PMC: 10541187.
DOI: 10.1172/JCI171356.
Comparing molecular and computational approaches for detecting viral integration of AAV gene therapy constructs.
Oziolor E, Kumpf S, Qian J, Gosink M, Sheehan M, Rubitski D
Mol Ther Methods Clin Dev. 2023; 29:395-405.
PMID: 37251978
PMC: 10209688.
DOI: 10.1016/j.omtm.2023.04.009.